14Dec
Financial Daily Dose 12.14.2020 | Top Story: AstraZeneca Acquires Alexion in $39 Billion Push into Immunology
Drugmaker AstraZeneca agreed on Saturday to buy biopharma company Alexion for $39 billion in cash and stock. In the deal—the “biggest by a health care company this year”—will help AstraZeneca expand into the immunology sector....
By:
Robins Kaplan LLP
Related
The Department of Labor recently issued a fact sheet intended to help employers understand their ret...
Read More >
On July 2, 2019, a three-judge panel of the Second Circuit reversed the lower court’s denial of a m...
Read More >
Fiduciaries of employee benefit plans subject to the Employee Retirement Income Security Act of 1974...
Read More >
Suppose a contractor or subcontractor is involved in a major renovation or expansion project such as...
Read More >
Non-essential in-person activities have been restricted in New York State during the ongoing COVID-1...
Read More >
Now that the calendar has flipped to 2020, planning and fundraising efforts are intensifying in adva...
Read More >